Cyteir Therapeutics Competitors and Similar CompaniesClear all

Cyteir Therapeutics's competitors and similar companies include DNAtriX, PACT Pharma, Anavex and Adagene.

	Cyteir Therapeutics Cyteir Therapeutics is a company that develops medicines for the treatment of cancer.	DNAtriX DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.	PACT Pharma PACT Pharma operates as a biotechnology company.	Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.	Adagene Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy.
Founding Date	Founding Date 2012	Founding Date 2005	Founding Date 2016	Founding Date 2006	Founding Date 2012
Type	Type Public	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech oncology pharmacy therapy	Tags Healthcare biotech clinical research drug development healthtech life sciences oncology pharma therapy	Tags Healthcare biotech clinical research drug development oncology therapy
Locations	Locations Lexington, US HQ	Locations Houston, US HQ San Diego, US	Locations South San Francisco, US HQ	Locations New York, US HQ Reno, US	Locations Suzhou, CN HQ San Diego, US San Francisco, US
Employees	Employees 4615% increase	Employees 350% increase	Employees 22	Employees 1623% increase	Employees 174
Valuation ($)	Valuation ($) 108.7 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 484.6 m	Valuation ($) 137.2 m
Financial
Net income	Net income ($46.1m) (FY, 2022)	Net income N/A	Net income N/A	Net income ($47.5m) (FY, 2023)	Net income ($18.9m) (FY, 2023)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 15.5m (about 6 years ago)	Latest funding round $ 75m (almost 5 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 76.7m	Total funding raised $ 54.2m	Total funding raised $ 200m	Total funding raised $ 12.6m	Total funding raised $ 155m